scispace - formally typeset
Journal ArticleDOI

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

J. W. Langston, +3 more
- 25 Feb 1983 - 
- Vol. 219, Iss: 4587, pp 979-980
Reads0
Chats0
TLDR
It is proposed that this chemical selectively damages cells in the substantia nigra in patients who developed marked parkinsonism after using an illicit drug intravenously.
Abstract
Four persons developed marked parkinsonism after using an illicit drug intravenously. Analysis of the substance injected by two of these patients revealed primarily 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) with trace amounts of 1-methyl-4-phenyl-4-propionoxy-piperidine (MPPP). On the basis of the striking parkinsonian features observed in our patients, and additional pathological data from one previously reported case, it is proposed that this chemical selectively damages cells in the substantia nigra.

read more

Citations
More filters
Journal ArticleDOI

Mitochondrial DNA analysis in Parkinson's disease.

TL;DR: Restriction fragment analysis of substantia nigra DNA from six patients with Parkinson's disease did not show any major deletion, and in two cases, there were different novel polymorphisms that were not observed in control brain or blood samples.
Journal ArticleDOI

Differential effects of PINK1 nonsense and missense mutations on mitochondrial function and morphology.

TL;DR: In this paper, the PINK1 gene mutations were found to cause abnormal mitochondrial morphology, bioenergetic function and oxidative metabolism in human tissues but suggest that the biochemical consequences may vary between mutations.

Environmental Toxins and Parkinson's Disease

TL;DR: The role of environmental and Occupational exposure to Chemicals in Parkinson’s Disease and the Nigrostriatal Pathway and PD is studied to determine the role of Oxidative Stress.
Journal ArticleDOI

Injury of nigral neurons exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: a tyrosine hydroxylase immunocytochemical study in monkey.

TL;DR: The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model should prove useful for investigating abnormalities occurring as a consequence of dysfunction of the nigrostriatal system, for examining processes associated with repair of damaged neuronal systems, and for developing and testing therapeutic approaches designed to prevent or ameliorate the Parkinsonian syndrome.
Journal ArticleDOI

The Neurodegenerative Mitochondriopathies

TL;DR: This review discusses what mitochondrial abnormalities have been identified in various neurodegenerative diseases, what is currently known about the mitochondria-neurodegeneration nexus, and speculates on the significance of mitochondrial function in some disorders not classically thought of as mitochondriopathies.
References
More filters
Journal ArticleDOI

Chronic Parkinsonism secondary to intravenous injection of meperidine analogues.

TL;DR: Biogenic amines and metabolites in the cerebrospinal fluid and microscopic evaluation of the brain at necropsy were consistent with damage to aminergic neurons in the substantia nigra.
Journal ArticleDOI

Apraxia of lid opening

TL;DR: Apraxia of lid opening is a nonparalytic motor abnormality characterized by the patient's difficulty in initiating the act of lid elevation and differs from paralytic ptosis by being present only momentarily at the start of lidOpening.
Related Papers (5)